The Activation of Hippo Pathway in Nasal Polyps

Status Recruiting

Clinical Trial Summary

Hippo-YAP pathway is a newly discovered pathway controlling the growth, and plays important roles in the regulation of stem cell function and tissue regeneration. Previously we found that a higher expression of YAP in NP, and LPS was able to activate the hippo-YAP pathway in NESCs. Thus, we hypothesize that the aberrant proliferation and differentiation of NESCs could be regulated via the hippo-YAP pathway.

Clinical Trial Description

Studies have shown that the development of nasal polyps (NP) are closely related to the epithelial remodeling.The investigators have shown that nasal epithelial stem cells(NESCs) derived from NP had reduced growth and proliferation dynamics in vitro culture,and differentiated into ciliated cells with impaired cilia architecture and ciliogenesis.Further studies demonstrated that NESCs were involved in the aberrant damage repair process of the epithelial remodeling in NP.Hippo-YAP pathway is a newly discovered pathway controlling the growth,and plays important roles in the regulation of stem cell function and tissue regeneration.Previously the investigators found that a higher expression of YAP in NP,and LPS was able to activate the hippo-YAP pathway in NESCs.Thus,the investigators hypothesize that the aberrant proliferation and differentiation of NESCs could be regulated via the hippo-YAP pathway,which may result in the epithelial remodeling.In this study,the investigators intend to investigate the mechanism of the hippo-YAP pathway in regulating aberrant proliferation and differentiation of NESCs and explore its upstream signaling and downstream target genes,using the NESCs gas-liquid interface culture system,and a silencing and overexpression of the hippo-YAP pathway component strategy.The investigators aim to unravel the effect and mechanism of the hippo-YAP pathway in the epithelial remodeling of NP,providing new targets and strategy for the improvement or reversal of NP epithelial remodeling. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT03151954
Study type	Interventional
Source	Third Affiliated Hospital, Sun Yat-Sen University
Contact	huiyi DENG, MD
Phone	15521127735
Email	deng.huiyi@foxmail.com
Status	Recruiting
Phase	N/A
Start date	April 20, 2017
Completion date	July 31, 2020

View Details

See also
Status	Clinical Trial	Phase
Withdrawn	`NCT02071667` - Association of Periostin Levels and Chronic Sinusitis	N/A
Completed	`NCT01623310` - 12-Month OL Intranasal Fluticasone Propionate BID Using OptiNose Device	Phase 3
Completed	`NCT02024659` - Effects and Safety of Budesonide Inhalation Suspension Via Transnasal Nebulization in Nasal Polyps	Phase 2/Phase 3
Completed	`NCT00215787` - Investigation of the Association Between Nasal Polyposis and Extraesophageal Reflux Disease	N/A
Completed	`NCT04996576` - Infrazygomatic Versus Intranasal Injection Sphinopalatine Ganglion Blockade Effect on Surgical Field in FESS	N/A
Recruiting	`NCT03963648` - NO Measurements in Screening for Asthma and OSA, in Patients With CRSwNP	N/A
Recruiting	`NCT05094570` - Interleukin-4Ra Blockade by Dupilumab Decreases Staphylococcus Colonization and Increases Microbial Diversity in CRSwNP	Phase 4
Recruiting	`NCT05009758` - Moving Towards Precision Medicine in United Airways Disease: Unraveling Inflammatory Patterns in Asthmatic Patients With or Without Nasal Polyps	N/A
Completed	`NCT00731185` - Mometasone Furoate Nasal Spray for Treatment of Nasal Polyposis After Surgery (Study P03218)	Phase 3
Active, not recruiting	`NCT03943121` - The Effects of Steroid-eluting Stent Implant for the Treatment of Eosinophilic Chronic Rhinosinusitis With Nasal Polyps	N/A
Active, not recruiting	`NCT03704415` - Aggravated Airway Inflammation: Research on Genomics and Optimal Operative Treatment (AirGOs Operative)	N/A
Not yet recruiting	`NCT06070311` - Wound Healing After Endoscopic Sinus Surgery	N/A
Completed	`NCT02879929` - Development and Validity of the DyNaChron Questionnaire for Chronic Nasal Dysfunction	N/A
Recruiting	`NCT05672030` - Role of IL-5R Signaling in Non-eosinophil Upper Airway Cells in CRSwNP
Suspended	`NCT04261582` - Genetics and Genomics of Aspirin Exacerbated Respiratory Disease (AERD)
Recruiting	`NCT05063981` - Treatment With Mepolizumab on Patients With Severe Refractory Eosinophilic Asthma With or Without CRSwNP.
Completed	`NCT05180357` - RANS. Study in Patients With Severe Eosinophilic Asthma and Nasal Polyps.
Completed	`NCT00788463` - A Comparison of Beclomethasone Aqueous Spray and Aerosol Delivery Systems in Nasal Polyps	Phase 2
Completed	`NCT01198912` - Influence of Oral Doxycycline on Wound Healing After Endonasal Endoscopic Sinus Surgery for Chronic Rhinosinusitis With and Without Nasal Polyposis: a Double-blind Randomized Placebo-controlled Trial	Phase 2
Completed	`NCT03280537` - A Clinical Trial of Omalizumab in Participants With Chronic Rhinosinusitus With Nasal Polyps	Phase 3

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.